Skip to content
  • Sunday, 26 July 2026
  • 2:54 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Glioblastoma Research Reveals Systemic Impact on Skull Bone and Immune Function
Stem Cell & Regenerative Medicine

Glioblastoma Research Reveals Systemic Impact on Skull Bone and Immune Function

Dwi Wanna Jul 22, 2026 0

Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have fundamentally challenged the…

Read More
Neuroscience & Brain Research

Oregon State University Researchers Develop Breakthrough Sugar-Coated Nanoparticle Delivery System to Combat Glioblastoma Brain Cancer

Rifan Muazin Jul 17, 2026 0

In a significant advancement for neuro-oncology, a research team at the Oregon State University College of Pharmacy has unveiled a…

Read More
Stem Cell & Regenerative Medicine

Glioblastoma Research Reveals Skull Erosion and Immune System Reprogramming Reshaping Treatment Strategies

Dwi Wanna Jun 30, 2026 0

The medical community has long viewed glioblastoma multiforme (GBM) as a localized, albeit highly aggressive, malignancy confined within the blood-brain…

Read More
Stem Cell & Regenerative Medicine

Regional Bone Marrow Niches in the Skull Identified as Critical Defense Hubs Against Aggressive Glioblastoma Tumors

Dwi Wanna Jun 3, 2026 0

Glioblastomas represent one of the most formidable challenges in modern oncology, remaining largely incurable despite decades of intensive research. These…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 31, 2026 0

Los Angeles, CA – A novel drug candidate for glioblastoma, KTM-101, developed by researchers at the University of California, Los…

Read More
Stem Cell & Regenerative Medicine

Glioblastoma Research Reveals Cancer Reshapes Skull Bone and Disrupts Systemic Immune Response to Fuel Tumor Growth

Dwi Wanna May 24, 2026 0

The traditional understanding of glioblastoma multiforme (GBM) as a localized malignancy confined within the blood-brain barrier is being fundamentally challenged…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 20, 2026 0

Los Angeles, CA – In a significant development offering renewed hope in the challenging landscape of brain cancer treatment, researchers…

Read More
Stem Cell & Regenerative Medicine

Localized Immune Reservoirs in the Skull Offer New Hope for Glioblastoma Treatment While Challenging Conventional Surgical Approaches

Dwi Wanna May 13, 2026 0

In a discovery that challenges decades of immunological dogma, researchers from the German Cancer Consortium (DKTK) at the West German…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 13, 2026 0

In a significant stride forward against one of the most formidable and lethal human cancers, researchers at UCLA have successfully…

Read More
Laboratory Automation & Robotics

UCLA Researchers Advance EGFR-Targeted Drug for Glioblastoma into Clinical Testing

Lana Keisha May 5, 2026 0

Researchers at UCLA have achieved a significant milestone in the arduous fight against glioblastoma, a notoriously aggressive and lethal form…

Read More

Posts pagination

1 2
The Impact of Daily Fluctuations in Mental Sharpness on Goal Pursuit and ProductivityA Sweeping Genetic Analysis Challenges the Single Ancestral Population Theory of Human OriginsWhat’s coming up at ASMS 2026?Cellares Raises $257M Series D to Automate Cell Therapy Manufacturing
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ